baber/WOPTO huggingface dataset:
Patent JP-2000515118-A (JP)
IPC: A61K31/549
Filed: 1995-12-28
Abstract: Substituted 6H-1,3,4-thiadiazin-2-amines of the following general formula: <CHEM>  wherein <CHEM> represents a morpholino, thiomorpholino, piperidino, pyrrolidino, or hexamethylenimino moiety, and pharmaceutically acceptable salts thereof which are used as anaesthetics, cardiovascular and hypometabolic agents, and the pharmaceutical compositions containing them.
Patent JP-H09505170-A (JP)
Title: ランタイムの短い乗算器
IPC: G06F7/533
Filed: 1995-03-21
Abstract: (57)【要約】
あらゆる乗算器形式において符号ビットの補足が、複数の加算器負荷の代わりに単純な負荷を作動させるだけでよいようにして行われる。このことで簡略化された回路によりランタイムが短くなる。
Patent JP-H08509725-A (JP)
Title: コートされた医薬組成物
IPC: A61K9/48
Filed: 1994-04-13
Abstract: (57)【要約】
組成物が、３‐１‐メントキシプロパン‐１，２‐ジオール、Ｎ‐置換‐ｐ‐メンタン‐３‐カルボキサミド、非環式カルボキサミド及びそれらの混合物からなる群より選択される揮発性芳香化合物により組成物の約０．０１〜約１０重量％でコートされている、単位剤形の経口投与用組成物を含む、コーティングに適した医薬組成物。
Patent JP-H10502446-A (JP)
Title: 乱流冷却ガス流を用いたゲル電気泳動時の温度勾配制御
IPC: G01N27/447
Filed: 1995-04-03
Abstract: (57)【要約】
ガス状熱交換媒体と、ガス状熱交換媒体を駆動する手段と、衝突手段との組み合わせから成り、前記ガス状熱交換媒体を前記衝突手段を介して前記ガス状熱交換媒体駆動手段により駆動してゲルプレートの表面上に前記ガス状熱交換媒体の流れを供給し、前記流れを前記ガス状熱交換媒体の前記衝突手段への通過により生ぜしめてゲル内の温度勾配を強制的な熱伝達作用により最小化することを特徴とするゲル電気泳動分離装置。
Patent JP-2000503853-A (JP)
IPC: C12N15/11
Filed: 1997-01-28
Abstract: The invention consists of recombinant gene expression vectors and vaccines useful in immunization of a host against an antigen and methods for use of such vectors and vaccines. In particular, the recombinant gene expression vectors of the invention are plasmids, cosmids or viruses which include non-coding, palindromic regions of single or double-stranded DNA or RNA polynucleotides which include at least one cytosine-guanine dinucleotide motif in each palindrome. These polynucleotide regions of each expression vector are immunostimulatory and serve as adjuvants to vaccination protocols against target antigens. Most preferably, the recombinant gene expression vectors of the invention are naked; i.e., non-viral vectors not associated with a delivery vehicle such as a liposome. The invention also includes live viral vaccines wherein the viruses include immunostimulatory polynucleotides of the invention. According to a preferred method of the invention, a target protein antigen is administered through its expression by a recombinant gene expression vector which contains the non-coding, immunostimulatory polynucleotides of the invention. In the most preferred embodiment of the method of the invention, the recombinant gene expression vector is administered to a tissues of the host which contain a relatively high concentration of antigen presenting cells (e.g., skin or mucosa) compared to other host tissues.
Patent JP-2000506248-A (JP)
Title: 軸線方向の変位割合変換器を含むロータ装置
IPC: F16C32/04
Filed: 1997-02-06
Abstract: (57)【要約】
特に、能動的な軸方向磁気軸受（１２）を有する、磁気軸受装置に懸垂されたシャフトであるロータ装置（１０）は、軸線方向のシャフトの変位センサ（２６）と、シャフトあるいは該シャフトに担持された機能要素の強磁性の肩形状部（３０）の軸線方向に露出された面と協働する変位割合変換器（３２）とを含む。変換器（３２）は、一対の環状の永久磁石の磁極片（３５、３６）の間の溝（３４）に配置された環状のピックアップコイルを含む環状の永久磁石の芯を含み、一方の対の極（３７’、３８’）が環状のキーパによって接合され、他方の極（３７、３８）が、肩形状部を通る磁束の通路を画成するエアギャップ（３９、４０）によって肩の面から分離されている。シャフトの変位によりエアギャップの長さが変動することによって生じる磁束密度の変動が変位の割合に関連したコイル電圧を誘発する。表面が高速で磁極片を通して並進する場合、コイルは回転軸線（１６）から半径方向外方に配置されるものの、環状の磁石はその他の変換器と相違してエアギャップを局部的に変動させる不規則があってもそれによって影響されない。
Patent JP-H11504093-A (JP)
Title: 内燃機関のシリンダの中に流入する空気流量をモデルを援用して求める方法
IPC: F02D41/14
Filed: 1996-04-09
Abstract: (57)【要約】
内燃機関のシリンダの中に流入する空気流量をモデルを援用して求める方法実際にシリンダの中に流入する空気流量を、次の入力変数すなわち絞り弁開度、周囲圧力及びバルブ制御を表すパラメータから負荷変数を供給する吸気管充填モデルを用いて計算し、負荷変数を基礎にして噴射時間が求められる。更にこの負荷変数は予測に用いられ、この予測により負荷変数が、噴射時間の現在の計算に比して少なくとも１つの標本化ステップだけ後に位置する時点で用いられる。
Patent JP-H11503938-A (JP)
Title: 小瓶ホルダ
IPC: A61J1/00
Filed: 1996-04-17
Abstract: (57)【要約】
小瓶が容易に充填され、小瓶を固く保持し、さらに小瓶を単純な形式で取り外すことができる小瓶ホルダが提供されている。また、小瓶ホルダは、２つの小瓶を同時に固く保持するために２つの小瓶保持区分を有している。
Patent JP-2001502124-A (JP)
IPC: H04H20/00
Filed: 1996-04-26
Abstract: A data management and distribution system for an electronic program guide ("EPG") for television programs comprising an automated data collection subsystem, a manual entry and correction subsystem, a database validation subsystem, an edition generation subsystem, a configuration subsystem, and a status and control subsystem. The system may further comprise a feed generation subsystem if one of more of the EPG providers supported by the EPG distributor requires a live feed of data. The automated data collection subsystem collects EPG data from multiple source sin various formats, filters the data based on the needs of the EPG providers supported, and places the data in a centralised database in a form suitable to support the different environmental contexts of the EPG providers. The manual entry and correction subsystem permits the EPG distributor to make manual correction, additions, and deletion to the data stored in the database. The database validation subsystem verifies the data stored in the database in accordance with designated verification options. The edition generation subsystem generates the different editions of the PEG for the different EPG providers supported by the EPG distributor. The configuration subsystem receives information from the various EPG providers and furnishes this information to the other subsystems which utilise the information in performing their respective tasks. The status and control subsystem monitors the operation of the data management and distribution system as a whole. The various feeds and editions are then transmitted to the EPG providers by eg satellite, wire, cable, etc. The EPG providers receive the feeds and editions and use them to provide one or both of a dedicated channel EPG and interactive EPG to subscribers.
Patent JP-H11505265-A (JP)
IPC: A61P37/00
Filed: 1996-05-09
Abstract: A method is disclosed that comprises administering insulin-like growth factor-I (IGF-I) to a mammal so as to sustain its biological activity in the mammal comprising administering a therapeutically effective amount of IGF-I to the mammal to provide an exposure to IGF-I for a period of time that stimulates the maximum biological response in the mammal, then discontinuing said administration for a period of time equal to or less than the time period used for administration, and repeating this pattern of administration and discontinuance of administration for a period as long as necessary to achieve or maintain the desired biological response in the mammal.
Patent JP-2000508640-A (JP)
IPC: A61P43/00
Filed: 1997-04-04
Abstract: PCT No. PCT/GB97/00959 Sec. 371 Date Oct. 5, 1998 Sec. 102(e) Date Oct. 5, 1998 PCT Filed Apr. 4, 1997 PCT Pub. No. WO97/37974 PCT Pub. Date Oct. 16, 1997The subject invention concerns mercaptoalkylacyl compounds of formula (I): The compounds of the subject invention can be used to inhibit matrix metalloproteinases and/or TNF alpha - and L-selectin sheddase-mediated diseases including degenerative diseases and cancers. The subject invention also concerns methods of using the compounds of the invention to treat or prevent conditions associated with matrix metalloproteinases or that are mediated by TNF alpha  or L-selectin sheddase.
Patent JP-H10503659-A (JP)
Title: アスペルギルス・ニゲル由来のアミノペプチダーゼの生産
IPC: A23C19/02
Filed: 1996-05-24
Abstract: (57)【要約】
アスペルギルス・ニゲル由来のアミノペプチダーゼ類を開示する。これらは、発酵培養液又はそれらの濃縮液中に生成することができ、実質的にエンドプロテアーゼを含まない。このようなアミノペプチダーゼは、食品工業、例えばパン生地又はチーズの製造において、有利に使用することができる。
Patent JP-2001514782-A (JP)
Title: コンピュータ用外部データ記憶ドライブ
IPC: G11B33/12
Filed: 1998-03-12
Abstract: (57)【要約】
外部ハードドライブは、それぞれの端部でＰＣ（ＰＣＭＣＩＡ）カード３にヒンジ結合された連結部材２と、異なる高さでラップトップコンピュータ７のＰＣ（ＰＣＭＣＩＡ）スロットの内部にカードが挿入されうるようにするハードドライブの本体部１とを備えている。電気的接続は、連結部材２におけるボアを通して延びる撓みうるプリント回路基板によって形成される。
Patent JP-2001514667-A (JP)
Title: 肝臓脂肪症の予防のための組成物
IPC: A61P3/06
Filed: 1997-03-17
Abstract: (57)【要約】
非経口的栄養素での長期の治療は、脂肪肝としても知られる肝脂肪症を誘導する傾向がある。腸内細菌との胆汁酸の長期の接触により引きおこされる毒性二次胆汁酸の形成量の増加及び腸内腔からのこれらの二次胆汁酸の吸収は、肝臓に毒性効果を与え、結果として肝脂肪症を導く。血清コレステロールを低下させるために便利に用いられる胆汁酸封鎖剤が、非経口的栄養素に関連した肝脂肪症を防止又は緩和することができることが発見された。任意に免疫栄養素、例えばオメガ−３ポリ不飽和脂肪酸、短鎖脂肪酸、グルタミン、アルギニン、酸化防止剤、リボ核酸又はヌクレオチドと組み合わせた、胆汁酸封鎖剤、好ましくはコチスチラミンの経口摂取は肝脂肪症を防止又は緩和することができる。本発明は、直接又は間接的に他の状態、例えば癌化学療法、敗血症、内毒素血症、火傷、傷ついた腸の機能、細菌のトランスロケーション又はAIDSから生じた肝脂肪症の防止又は緩和にも関する。
Patent JP-2000510123-A (JP)
Title: ウイルス感染の治療方法
IPC: A61P31/00
Filed: 1997-05-07
Abstract: (57)【要約】
本発明は、被験者のウイルス感染を処置するための方法を提供する。この方法は、５−アミノレブリン酸の一定量を被験者に投与し、ウイルス感染細胞にプロトポルフィリンを蓄積させ、ここで、５−アミノレブリン酸の一定量とは、赤色光を十分量で適用したときに、ウイルス感染プロトポルフィリン蓄積細胞が破壊されるような量であり；前記ウイルス感染プロトポルフィリン蓄積細胞に十分量の赤色光を適用し、これを破壊することを特徴とする方法である。
Patent JP-2001524020-A (JP)
IPC: C02F1/44
Filed: 1998-04-02
Abstract: There is described a method of processing waste water, in particular from malt factories and breweries, which in the operational use is contaminated with microorganisms, salts and organic compounds. To enable a reuse, it is proposed to subject the waste water to a reverse osmosis after a treatment with activated sludge, before it is recirculated to the operational use.
Patent JP-2000511378-A (JP)
Title: アクセス制御付きのテレビ予約システム
IPC: H04N7/16
Filed: 1997-05-23
Abstract: (57)【要約】
本発明は、時間、格付け、内容および／またはチャネル別にユーザーがテレビ番組へのアクセスを制御する事を可能とするユーザーインターフェース（３８）を備えたテレビ予約システム（１）に関する。更にユーザーは、ＰＰＶ番組の購入を制限するペイパービュー（ＰＰＶ）消費の限界をセットすることができる。
Patent JP-2001519014-A (JP)
IPC: F16L55/16
Filed: 1998-03-30
Abstract: The invention concerns a reversion device (10) for fixing flexible and sealing sheaths (30) for reconditioning or protecting pipe lines by internal or external jacketing, comprising a reversion chamber (20) capable of being pressurised by means of a compressed gas wherein the sheath is gradually introduced as the reversion process is carried out through an insertion slot (40) comprising means for limiting compressed gas leaks.
Patent JP-2001518843-A (JP)
IPC: B01F25/60
Filed: 1998-04-07
Abstract: A process and apparatus for the mixing of material by means of the combination of sheer-dispersion and/or extensional-dispersion and distributive mixing actions, in which the mixing occurs in one or more stages within stress inducing flow channels between movable members whereby the material is essentially propelled through the flow channels of such stages by pumping actions provided by the relative movement between the members within the mixer itself.
Patent MD-20010210-A (MD)
Title: Composition for electrodes
Inventor: SAFRONOV ION
IPC: C22C38/06
Filed: 2001-07-04
Abstract: The invention relates to the materials used in the capacity of electrodes for electroslag welding of large-section structures of high-strength chromium nickel molybdenum steels. The composition for electrodes contains carbon, manganese, nickel, molybdenum, vanadium, cerium and iron. Novelty consists in that the composition additionally contains wolfram, titanium and aluminum, in the following component ratio, mass %:carbon 		0,01...0,04manganese 	3,5...15,0nickel 		4,0...12,0molybdenum 	1,0...4,0vanadium 		0,01...1,2cerium 		0,001...1,5wolfram 		0,01...2,5titanium		0,05...1,0aluminum 		0,05...1,5iron 		the rest.The alloying system with the proposed compositions permitted obtaining of welds with ferritic structure, possessing serviceability at low temperatures, resistance to the formation of pores and shrinkage cracks.Claims: 1
Patent NZ-180233-A (NZ)
Title: 11-substituted-17a -hydroxy-3-oxo-d-homo-androst-a-ene-17a -carboxylic acids
Inventor: FUERST A
IPC: A61K31/22
Filed: 1976-03-29
Abstract: The present disclosure relates to steroid carboxylic acids and derivatives thereof. More particularly, the disclosure is concerned with D-homosteroid carboxylic acids and their derivatives, a process for the preparation thereof and pharmaceutical compositions containing same. The instant compounds are active endocrinal agents, especially as antiinflammatory agents.
Patent NZ-202850-A (NZ)
Title: Method of joining carpet using a reinforced adhesive tape and an electrically heated paper backed foil heating element
Inventor: BROOKS R H
IPC: C09J7/35
Filed: 1982-12-20
Abstract: A method and apparatus for adhesively bonding together in edge abutting relationship two sheets of woven, felted, or other textile material such as carpet using a joining tape which includes a removable electrically conductive foil and layer of heat so/tenable adhesive. The control circuit maintains the adhesive in a tacky state while the abutting edges which overlap the tape are adjusted as required to form the desired joint.
Patent NZ-208880-A (NZ)
Title: Leukotriene antagonists
Inventor: DILLARD R D
IPC: C07C59/90
Filed: 1984-07-12
Abstract: This invention provides novel benzene derivatives which are leukotriene antagonists, formulations of those derivatives, intermediates for preparing the derivatives, and a method of using those derivatives for the treatment of conditions characterized by an excessive release of leukotrienes.
Patent NZ-215283-A (NZ)
Title: Increasing rigidity of rifle action receiver
Inventor: BROWN E
IPC: F41C23/00
Filed: 1986-02-25
Abstract: This relates to a method and apparatus for increasing the rigidity of a conventional pre-existing rifle action receiver (10) of the type which includes a cartridge magazine port having first and second longitudinal edges, an ejection port (17), and a bolt which reciprocates within the receiver to engage a cartridge and urge it into a chamber at the rearward end of a barrel which is secured into a threaded opening in the front of the receiver (10). Apertured first and second plates (24, 25) are fixedly coupled proximate the first and second edges of the magazine port and extend downwardly therefrom. The apertures (27) can serve to reduce weight and at least one aperture can be used to secure an insert between the plates, so that weight and balance can be altered.
Patent NZ-221201-A (NZ)
Title: Synthesis of penemallyl esters
Inventor: BRIGHTY KATHERINE ELIZABETH
IPC: C07F7/18
Filed: 1987-07-27
Abstract: A process for the synthesis of penems from azetidinones via 1-aza-4,5-dithiabicyclo[4.2.0]oct-2-en-8-one-2-carboxylate esters.
Patent NZ-221543-A (NZ)
Title: 4-aminoquinoline derivatives and pharmaceutical compositions containing such
Inventor: EFFLAND RICHARD CHARLES
IPC: C07D215/42
Filed: 1987-08-24
Abstract: There are described compounds of the formula <CHEM> where X is hydrogen, halogen, loweralkyl, loweralkoxy or trifluoromethyl;   R is - @-R4 or -@@-R4, R4 being loweralkyl; R1 is hydrogen, loweralkyl or arylloweralkyl; R2 is hydrogen, loweralkyl or arylloweralkyl; and R3 is loweralkyl, with the proviso that when R is acetyl, R3 is methyl and X is hydrogen, R1 and R2 are not both hydrogen, or pharmaceutically acceptable acid addition salts thereof, which are useful for enhancing memory and for treating Alzheimer's disease.
Patent NZ-229443-A (NZ)
Title: Encapsulation of heat sensitive polymer prior to sheet extrusion
Inventor: BLEMBERG ROBERT JOHN
IPC: B29C48/495
Filed: 1989-06-07
Abstract: Method and apparatus for fabricating multiple layer sheet materials are adapted to minimize the time of exposure of a sensitive polymeric melt stream to contact with metal. The method comprises encapsulating the sensitive melt stream (12) with a second polymeric melt stream (16) which preferably is of a lower viscosity, at the outlet of the apparatus or extruder (10) which produces the sensitive melt stream (12). When the encapsulating melt stream (16) has a lower viscosity than the sensitive melt stream, a transport means (36) - an elongated pipe - is preferably employed between the encapsulating means (20) and an extrusion die (42), whereby thickness variations about the circumference of the encapsulating melt stream (16) are reduced. The method and apparatus are especially beneficial for the extrusion of vinylidene chloride copolymers in the manufacture of multi-layer packaging films containing one or more layers of VDC copolymers. <IMAGE>   <IMAGE>
Patent NZ-240045-A (NZ)
Title: Hydroxy vinyl phosphonic acid polymers; preparation thereof and use in stabilising hydrogen peroxide solutions
Inventor: VAN HEMELRIJK DIRCK
IPC: C08F8/12
Filed: 1991-10-01
Abstract: PCT No. PCT/EP91/01846 Sec. 371 Date Jun. 2, 1993 Sec. 102(e) Date Jun. 2, 1993 PCT Filed Sep. 9, 1991 PCT Pub. No. WO92/06122 PCT Pub. Date Apr. 16, 1992.    <IMAGE>  (I)    Organophosphonic polymers of general formula (I) where Y is a methyl or ethyl group or hydrogen and Z is hydrogen, the ammonium group, an alcaline metal or an alcaline earth metal. A method for producing these polymers comprises three stages: production of a monomer by reacting a ketene with diethylphosphite in the presence of an acid catalyst; polymerization of the monomer in solution in a solvent by means of a free radical initiator; hydrolysis of the polymer obtained by means of a concentrated solution of inorganic or inorganic based acid. Aqueous solution of hydrogen peroxyde stabilized by means of said polymers.
Patent NZ-240780-A (NZ)
Title: Shoe with a central fastener
Inventor: BERGER CHRISTOPH
IPC: A43C11/16
Filed: 1991-11-28
Abstract: The invention concerns a shoe, in particular a shoe for sport, leisure or rehabilitation purposes, with a centrally positioned clasp mounted on a dimensionally stable instep covering which can be moved towards or away from the instep. The clasp is designed so that it can be used with shoes having uppers made of material which is flexible with respect to tensional forces, i.e. with shoes which do not have dimensionally stable sheath-like uppers. This is achieved by virtue of the fact that the centrally positioned clasp (24) is fitted on a mounting plate (23) which is attached to a flexible tongue (15). The mounting plate (23) is significantly smaller than the length on the instep (26), thus allowing substantial parts of the tongue (15) to remain flexible.
Patent NZ-240980-A (NZ)
Title: Polyester fixative composition for hair
Inventor: GALLEGUILLOS RAMIRO
IPC: A61K8/85
Filed: 1991-12-13
Abstract: A composition that protects the hair from thermal damage and doubles as an excellent hair styling aid, in the form of a hair spray, mousse foam or gel composition, and method of applying the composition to hair prior to substantial configuring of the hair in its final configuration. After application of the composition to wet or dry hair, prior to styling, the applied composition, including a polymer having a Tg less than about 120 DEG C, is heated to the glass transition temperature of the polymer, while the hair is in the desired configuration, and thereafter the heat is removed from the polymer to cool it to a temperature below its glass transition temperature to harden the polymer in a shape complimentary to that of the desired final hair configuration. The thermoplastic polymer fixative may include a plurality of sulfonated dicarboxylic acid moieties and/or neutralized sulfonate moietie. The composition includes a water and/or alcohol carrier, and a water-soluble or alcohol-soluble thermoplastic fixative polymer or resin in an amount of at least about 0.1% up to about 20% by weight of the composition, but below a level at which adjacent hair shafts are adhered together, and preferably, in an amount in the range of about 0.5% to about 4% of the composition, particularly about 0.5% to about 3% by weight of the composition. <IMAGE>
Patent NZ-247275-A (NZ)
Title: Process and apparatus for hydrolysing proteins involving hydrolysis in a stirred tank and a second hydrolysis in a tube
Inventor: BAENSCH JOHANNES
IPC: C12M1/06
Filed: 1993-03-29
Abstract: Process and apparatus for the enzymatic hydrolysis of proteins, in which a proteolytic enzyme and a protein substrate are mixed, a first step of hydrolysis is carried out in a tank, with stirring, and a second step of hydrolysis is carried out in a tube provided with static mixing elements. <IMAGE>
Patent NZ-296732-A (NZ)
Title: Information processing system involving a time trial of learning and performance
Inventor: JANNARONE ROBERT J
IPC: G06V10/771
Filed: 1995-11-01
Abstract: This processing system  for computing output values from input values received during a series of time trials comprises a processing unit operative to receive an input vector comprising a plurality of input data values for each time trial and a memory unit, connected to the processing unit, containing elements defining a connection weight matrix that is the inverse of a covariance matrix based on regression analysis applied to input data values received during prior time trials; The processing unit is operative to provide, during each time trial, one or more outputs values calculated as a function of the input data values for the time trial and the elements of the connection weight matrix. The processing unit is operative to update the elements of the connection weight matrix, during each time trial, based on covariance relationships among the input values received during the time trial.
Patent NZ-300903-A (NZ)
Title: Use of hyaluronic acid having an mr of not less than 20000 daltons for the treatment of cystitis
Inventor: MORALES ALVARO
IPC: C08B37/08
Filed: 1996-02-14
Abstract: A method of treating interstitial cystitis comprising contacting the transitional epithelium lining the urinary bladder and associated structures in a mammal having interstitial cystitis with a solution containing hyaluronic acid having a average molecular weight of not less than 2x105 Daltons in a concentration effective to treat the interstitial cystitis.
Patent NZ-306849-A (NZ)
Title: Fluid container and mount combination, typically for bicycle mounting, with container having interior channel and mount having interengaging projection
Inventor: MCGEE JOHN W
IPC: B62J11/00
Filed: 1996-04-23
Abstract: A fluid-holding container and a member for mounting the container to an object. The fluid-holding container is formed to have a concave bottom portion and sidewalls connected to the bottom portion. At the center of the bottom portion, a channel extends into the interior of the fluid-holding container. The channel is adapted to engage with a securing post of a mounting member. The mounting member includes a base portion that is attached to the object. The distance between the sidewalls and the center axis of the fluid-holding container is substantially equal to the distance between the center of the securing post and the base portion, thus assuring a secure attachment of the container to the mounting member. The present invention is suitable for use in mounting a water bottle to a bicycle.
Patent NZ-307854-A (NZ)
Title: Transcriptional control sequences which regulate gene expression in plant tissue in response to invading microbial pathogens and elicitor inducing chemical signals
Inventor: CHAPPELL JOSEPH
IPC: C12N9/10
Filed: 1996-05-07
Abstract: Using a DNA molecule including a nucleotide sequence encoding an elicitin protein operably linked to and expressed under the regulatory control of an inducible transcription regulatory element to produce a transgenic plant with improved disease resistance includes providing a nucleotide sequence encoding a heterologous coding sequence of an elicitin protein operably linked to an inducible transcription regulatory element and a promoter functional in a plant cell to produce an inducible expression construct.  The construct is cloned into a plasmid vector adapted for use in a plant cell to produce an inducible expression vector which is introduced into plant tissue to produce transgenic plant tissue.   The transgenic plant tissue is regenerated to produce a transgenic plant in which the elicitin is expressed in response to potential plant pathogen invasion or elicitor treatment of the transgenic plant to induce the hypersensitive response increasing the resistance of the transgenic plant to the plant pathogen.